Protocols of dual diagnosis intervention in schizophrenia

Carlos Roncero, Carmen Barral, Lara Grau-Lopez, Diana Bachiller, Néstor Szerman, Miguel Casas, Pedro Ruiz

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: To review the existing literature on the psychopharmacological and psychotherapeutic treatment of patients with both schizophrenia and a substance use disorder (SUD). Methods: Selective review of the literature. PubMed search until November 2010. Results: Patients with psychotic disorders also frequently have SUDs. To attempt to explain their high coexistence there are different hypotheses, such as self-medication or the drug induction theories of chronic psychosis. Pathogenesis mechanisms are unknown. Patients may use substances to control or minimize symptoms such as hallucinations or anxiety, for the management of negative emotional states, to counteract negative symptoms and as a means of integration into a group. The diagnosis is complicated. It is important to correctly identify these patients because they have a more severe psychopathology, a more violent social behavior, and have more comorbidity with other medical diseases (such as human immunodeficiency virus or hepatitis C virus), which worsens the prognosis. The knowledge of the clinical characteristics and needs of these patients should enable suitable treatment programs to be developed. Conclusions: Substance abuse worsens the course and prognosis of schizophrenia and makes the psychopharmacological treatment and psychotherapeutic approach more difficult. Dual psychotics are characterized by low adherence to treatment and poor linkage to health facilities. Therefore, the integrated treatment model, in which the same therapeutic team jointly addresses schizophrenia and SUD, is offered as a therapeutic option of choice in managing these patients.

Original languageEnglish
Pages (from-to)131-154
Number of pages24
JournalAddictive Disorders and their Treatment
Volume10
Issue number3
DOIs
StatePublished - Sep 1 2011
Externally publishedYes

Fingerprint

Dual (Psychiatry) Diagnosis
Schizophrenia
Substance-Related Disorders
Psychotic Disorders
Therapeutics
Self Medication
Social Behavior
Hallucinations
Health Facilities
Psychopathology
PubMed
Hepacivirus
Comorbidity
Anxiety
HIV

Keywords

  • alcohol
  • cannabis
  • cocaine
  • dual diagnosis
  • dual disorder
  • heroin
  • pharmacotherapy
  • schizophrenia
  • substance use disorder
  • treatment

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health

Cite this

Roncero, C., Barral, C., Grau-Lopez, L., Bachiller, D., Szerman, N., Casas, M., & Ruiz, P. (2011). Protocols of dual diagnosis intervention in schizophrenia. Addictive Disorders and their Treatment, 10(3), 131-154. https://doi.org/10.1097/ADT.0b013e318227ecdc

Protocols of dual diagnosis intervention in schizophrenia. / Roncero, Carlos; Barral, Carmen; Grau-Lopez, Lara; Bachiller, Diana; Szerman, Néstor; Casas, Miguel; Ruiz, Pedro.

In: Addictive Disorders and their Treatment, Vol. 10, No. 3, 01.09.2011, p. 131-154.

Research output: Contribution to journalArticle

Roncero, C, Barral, C, Grau-Lopez, L, Bachiller, D, Szerman, N, Casas, M & Ruiz, P 2011, 'Protocols of dual diagnosis intervention in schizophrenia', Addictive Disorders and their Treatment, vol. 10, no. 3, pp. 131-154. https://doi.org/10.1097/ADT.0b013e318227ecdc
Roncero C, Barral C, Grau-Lopez L, Bachiller D, Szerman N, Casas M et al. Protocols of dual diagnosis intervention in schizophrenia. Addictive Disorders and their Treatment. 2011 Sep 1;10(3):131-154. https://doi.org/10.1097/ADT.0b013e318227ecdc
Roncero, Carlos ; Barral, Carmen ; Grau-Lopez, Lara ; Bachiller, Diana ; Szerman, Néstor ; Casas, Miguel ; Ruiz, Pedro. / Protocols of dual diagnosis intervention in schizophrenia. In: Addictive Disorders and their Treatment. 2011 ; Vol. 10, No. 3. pp. 131-154.
@article{46deb38ed8aa49bdb531aa55c04c5487,
title = "Protocols of dual diagnosis intervention in schizophrenia",
abstract = "Objective: To review the existing literature on the psychopharmacological and psychotherapeutic treatment of patients with both schizophrenia and a substance use disorder (SUD). Methods: Selective review of the literature. PubMed search until November 2010. Results: Patients with psychotic disorders also frequently have SUDs. To attempt to explain their high coexistence there are different hypotheses, such as self-medication or the drug induction theories of chronic psychosis. Pathogenesis mechanisms are unknown. Patients may use substances to control or minimize symptoms such as hallucinations or anxiety, for the management of negative emotional states, to counteract negative symptoms and as a means of integration into a group. The diagnosis is complicated. It is important to correctly identify these patients because they have a more severe psychopathology, a more violent social behavior, and have more comorbidity with other medical diseases (such as human immunodeficiency virus or hepatitis C virus), which worsens the prognosis. The knowledge of the clinical characteristics and needs of these patients should enable suitable treatment programs to be developed. Conclusions: Substance abuse worsens the course and prognosis of schizophrenia and makes the psychopharmacological treatment and psychotherapeutic approach more difficult. Dual psychotics are characterized by low adherence to treatment and poor linkage to health facilities. Therefore, the integrated treatment model, in which the same therapeutic team jointly addresses schizophrenia and SUD, is offered as a therapeutic option of choice in managing these patients.",
keywords = "alcohol, cannabis, cocaine, dual diagnosis, dual disorder, heroin, pharmacotherapy, schizophrenia, substance use disorder, treatment",
author = "Carlos Roncero and Carmen Barral and Lara Grau-Lopez and Diana Bachiller and N{\'e}stor Szerman and Miguel Casas and Pedro Ruiz",
year = "2011",
month = "9",
day = "1",
doi = "10.1097/ADT.0b013e318227ecdc",
language = "English",
volume = "10",
pages = "131--154",
journal = "Addictive Disorders and their Treatment",
issn = "1531-5754",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Protocols of dual diagnosis intervention in schizophrenia

AU - Roncero, Carlos

AU - Barral, Carmen

AU - Grau-Lopez, Lara

AU - Bachiller, Diana

AU - Szerman, Néstor

AU - Casas, Miguel

AU - Ruiz, Pedro

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Objective: To review the existing literature on the psychopharmacological and psychotherapeutic treatment of patients with both schizophrenia and a substance use disorder (SUD). Methods: Selective review of the literature. PubMed search until November 2010. Results: Patients with psychotic disorders also frequently have SUDs. To attempt to explain their high coexistence there are different hypotheses, such as self-medication or the drug induction theories of chronic psychosis. Pathogenesis mechanisms are unknown. Patients may use substances to control or minimize symptoms such as hallucinations or anxiety, for the management of negative emotional states, to counteract negative symptoms and as a means of integration into a group. The diagnosis is complicated. It is important to correctly identify these patients because they have a more severe psychopathology, a more violent social behavior, and have more comorbidity with other medical diseases (such as human immunodeficiency virus or hepatitis C virus), which worsens the prognosis. The knowledge of the clinical characteristics and needs of these patients should enable suitable treatment programs to be developed. Conclusions: Substance abuse worsens the course and prognosis of schizophrenia and makes the psychopharmacological treatment and psychotherapeutic approach more difficult. Dual psychotics are characterized by low adherence to treatment and poor linkage to health facilities. Therefore, the integrated treatment model, in which the same therapeutic team jointly addresses schizophrenia and SUD, is offered as a therapeutic option of choice in managing these patients.

AB - Objective: To review the existing literature on the psychopharmacological and psychotherapeutic treatment of patients with both schizophrenia and a substance use disorder (SUD). Methods: Selective review of the literature. PubMed search until November 2010. Results: Patients with psychotic disorders also frequently have SUDs. To attempt to explain their high coexistence there are different hypotheses, such as self-medication or the drug induction theories of chronic psychosis. Pathogenesis mechanisms are unknown. Patients may use substances to control or minimize symptoms such as hallucinations or anxiety, for the management of negative emotional states, to counteract negative symptoms and as a means of integration into a group. The diagnosis is complicated. It is important to correctly identify these patients because they have a more severe psychopathology, a more violent social behavior, and have more comorbidity with other medical diseases (such as human immunodeficiency virus or hepatitis C virus), which worsens the prognosis. The knowledge of the clinical characteristics and needs of these patients should enable suitable treatment programs to be developed. Conclusions: Substance abuse worsens the course and prognosis of schizophrenia and makes the psychopharmacological treatment and psychotherapeutic approach more difficult. Dual psychotics are characterized by low adherence to treatment and poor linkage to health facilities. Therefore, the integrated treatment model, in which the same therapeutic team jointly addresses schizophrenia and SUD, is offered as a therapeutic option of choice in managing these patients.

KW - alcohol

KW - cannabis

KW - cocaine

KW - dual diagnosis

KW - dual disorder

KW - heroin

KW - pharmacotherapy

KW - schizophrenia

KW - substance use disorder

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=80052228531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052228531&partnerID=8YFLogxK

U2 - 10.1097/ADT.0b013e318227ecdc

DO - 10.1097/ADT.0b013e318227ecdc

M3 - Article

VL - 10

SP - 131

EP - 154

JO - Addictive Disorders and their Treatment

JF - Addictive Disorders and their Treatment

SN - 1531-5754

IS - 3

ER -